The Apollon medical cannabis formulations are an opportunity for more men to have their prostate cancer treated.
MGC Pharma anticipates that the patent for its novel SNEDDS formulation will be issued within the coming 12 months.
The first cannabis company to IPO on LSE, Kanabo, has launched a new extract formula that will give thousands of UK patients access to pain relief...
Oxford Cannabinoid Technologies has signed a deal with drug development firm Evotec as it moves towards Phase 1 clinical trials in humans.
It's been described as a "historic" moment for the sector.
The pilot study, which will be ran by Medicann, will collect data on various strains.
The Israeli-French partnership will produce a study of cannabis-based vaginal health products.
Emerson has partnered with cannabis executive Liam McGreevy to launch Elite Pharmaco.
The company's experimental treatment for severe epilepsy will be covered by the health service.
Patient data shows how thousands are ditching opioids in favour of cannabis to treat pain conditions.